Summit X, LLC 9 Meters Biopharma, Inc. Transaction History

Summit X, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$0.21 - $0.32 $840 - $1,280	-4,000 Reduced 23.81%	12,800 $1,000
Q1 2022 May 05, 2022	BUY	$0.52 - $1.0 $2,600 - $5,000	5,000 Added 42.37%	16,800 $10,000
Q4 2021 Jan 19, 2022	SELL	$0.85 - $1.33 $2,975 - $4,655	-3,500 Reduced 22.88%	11,800 $11,000
Q2 2021 Jul 16, 2021	SELL	$1.04 - $1.5 $6,240 - $9,000	-6,000 Reduced 28.17%	15,300 $17,000
Q1 2021 May 10, 2021	SELL	$0.84 - $2.16 $8,148 - $20,952	-9,700 Reduced 31.29%	21,300 $24,000
Q4 2020 Jan 29, 2021	SELL	$0.65 - $1.11 $7,800 - $13,320	-12,000 Reduced 27.91%	31,000 $20,000
Q3 2020 Nov 12, 2020	BUY	$0.48 - $0.84 $2,400 - $4,200	5,000 Added 13.16%	43,000 $9,000
Q2 2020 Aug 13, 2020	BUY	$0.43 - $0.74 $16,340 - $28,120	38,000 New	38,000 $22,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.